Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused ...

YolTech Therapeutics, a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines, today reported positive results from ...

By adjusting the fat levels in mRNA-based drugs, researchers have found a way to bypass the liver and go straight to the ...

A new LNP-mRNA vaccine significantly boosts immune response and enhances BCG protection against tuberculosis, offering a ...

Creative Biolabs With the enabling platforms and technologies at its disposal, Creative Biolabs is poised to address critical challenges in ...

Imagine if antibodies, proteins such as insulin, or even COVID-19 and flu vaccines could be consumed orally instead of via ...